Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model

v3.20.1
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model
9 Months Ended
Mar. 31, 2020
$ / shares
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]  
Dividend yield 0.00%
Weighted Average Grant Date Fair Value of Options granted during the period (in Dollars per share) $ 4.26
Minimum [Member]  
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]  
Exercise price (in Dollars per share) $ 4.71
Expected term (years) 4 years 9 months
Risk-free interest rate 0.64%
Volatility 65.00%
Maximum [Member]  
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]  
Exercise price (in Dollars per share) $ 8.09
Expected term (years) 5 years
Risk-free interest rate 1.74%
Volatility 67.00%